four-parameter log(dose) versus response nonlinear regression (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
four-parameter log(dose) versus response nonlinear regression
Four Parameter Log(dose) Versus Response Nonlinear Regression, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software%2C+algorithm/four+parameter+log+inhibitor++versus+response+algorithm/pmc06093241-531-13-17
Average 90 stars, based on 1 article reviews
Four Parameter Log(dose) Versus Response Nonlinear Regression, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/software%2C+algorithm/four+parameter+log+inhibitor++versus+response+algorithm/pmc06093241-531-13-17
Average 90 stars, based on 1 article reviews
four-parameter log(dose) versus response nonlinear regression - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Efficacy and in vitro pharmacological assessment of novel N -hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors. Article Snippet: We previously reported N-hydroxypyridinedione (HPD) compounds with mid-nanomolar efficacy and selectivity indexes around 300 against hepatitis B virus (HBV) replication.. However, they lack pharmacological evaluation.. Here, we report in vitro anti-HBV efficacy, cytotoxicity, and pharmacological characterization of 29 novel HPDs within seven subgroups. Article Title: Efficacy and in vitro pharmacological assessment of novel N -hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors Article Snippet: IC 50 values were determined using the four-parameter log[inhibitor] versus response algorithm in Generated:Article Title: Efficacy and in vitro pharmacological assessment of novel N -hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors. Article Snippet: We previously reported N-hydroxypyridinedione (HPD) compounds with mid-nanomolar efficacy and selectivity indexes around 300 against hepatitis B virus (HBV) replication.. However, they lack pharmacological evaluation.. Here, we report in vitro anti-HBV efficacy, cytotoxicity, and pharmacological characterization of 29 novel HPDs within seven subgroups. Article Title: Efficacy and in vitro pharmacological assessment of novel N -hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors Article Snippet: IC 50 values were determined using the four-parameter log[inhibitor] versus response algorithm in |